Post-Pandemic World: Binah.AI CEO Expects Vital Sign Screening To Take Flight – Literally

Israel-based start-up Binah’s CEO David Maman predicts screening technologies that detect vital signs in real time will be in high demand in the post-pandemic economy.

Young man with backpack touching interactive display at self-service transfer machine, doing self-check-in for flight or buying airplane tickets at automatic device in modern airport terminal building

David Maman, co-founder and CEO of Israel-based digital health company Binah.ai predicts the demand for vital sign monitoring technology will continue its acceleration into hospitals and health systems. But it will also reach into other areas of public life such as airports, food manufacturing plants, offices and other workplaces to thwart the ongoing threat of coronavirus.

“This is the next generation of business continuity, making sure that the health of the workforce is not being infected,”...

More from Digital Technologies

More from Medtech Insight

India’s MedTech Future Hinges On Regulatory Reform And Global Alignment: MTaI’s Pavan Choudary

 
• By 

In this in-depth interview with Medtech Insight, Pavan Choudary unpacks the implications of recent free trade agreements (FTAs) such as India’s with the UK, the potential fallout from new US tariffs on Indian device exports, and the pressing need for regulatory harmonization.

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By 

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By 

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.